1. Home
  2. BDX vs MFG Comparison

BDX vs MFG Comparison

Compare BDX & MFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDX
  • MFG
  • Stock Information
  • Founded
  • BDX 1897
  • MFG 2003
  • Country
  • BDX United States
  • MFG Japan
  • Employees
  • BDX N/A
  • MFG 52307
  • Industry
  • BDX Medical/Dental Instruments
  • MFG Major Banks
  • Sector
  • BDX Health Care
  • MFG Finance
  • Exchange
  • BDX Nasdaq
  • MFG Nasdaq
  • Market Cap
  • BDX 65.8B
  • MFG 61.0B
  • IPO Year
  • BDX 1962
  • MFG 2000
  • Fundamental
  • Price
  • BDX $227.81
  • MFG $4.83
  • Analyst Decision
  • BDX Strong Buy
  • MFG
  • Analyst Count
  • BDX 6
  • MFG 0
  • Target Price
  • BDX $283.50
  • MFG N/A
  • AVG Volume (30 Days)
  • BDX 2.4M
  • MFG 934.8K
  • Earning Date
  • BDX 02-06-2025
  • MFG 01-31-2025
  • Dividend Yield
  • BDX 1.83%
  • MFG 1.46%
  • EPS Growth
  • BDX 18.61
  • MFG 30.13
  • EPS
  • BDX 5.86
  • MFG 2.28
  • Revenue
  • BDX $20,178,000,000.00
  • MFG $25,014,848,091.00
  • Revenue This Year
  • BDX $10.16
  • MFG N/A
  • Revenue Next Year
  • BDX $5.05
  • MFG $3.17
  • P/E Ratio
  • BDX $38.85
  • MFG $10.52
  • Revenue Growth
  • BDX 4.16
  • MFG 12.06
  • 52 Week Low
  • BDX $218.75
  • MFG $3.34
  • 52 Week High
  • BDX $249.89
  • MFG $5.31
  • Technical
  • Relative Strength Index (RSI)
  • BDX 53.84
  • MFG 45.87
  • Support Level
  • BDX $222.82
  • MFG $4.83
  • Resistance Level
  • BDX $231.74
  • MFG $5.00
  • Average True Range (ATR)
  • BDX 4.43
  • MFG 0.07
  • MACD
  • BDX 0.89
  • MFG -0.06
  • Stochastic Oscillator
  • BDX 69.53
  • MFG 16.38

About BDX Becton Dickinson and Company

Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.

About MFG Mizuho Financial Group Inc. Sponosred ADR (Japan)

Mizuho Financial Group is roughly tied with megabank peer Sumitomo Mitsui Financial Group for the status as Japan's second-largest bank after Mitsubishi UFJ Financial Group. As of March 2024, Mizuho's market share of domestic loans was 6.8%, compared with 7.2% for SMFG and 8.0% for MUFG. In Japan, Mizuho has more of a corporate focus than SMFG, which has a larger retail business. Its overseas weighting is slightly smaller than that of MUFG. Unlike its two Japanese megabank peers that own foreign banks outright or hold noncontrolling stakes in local banks overseas, Mizuho expanded in recent years beyond its traditional Japanese borrowers, mainly through its core banking and securities units, focusing on the financing needs of global multinational corporations.

Share on Social Networks: